These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35673987)

  • 1. Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin.
    Cheraga N; Ye Z; Xu MJ; Zou L; Sun NC; Hang Y; Shan CJ; Yang ZZ; Chen LJ; Huang NP
    Nanoscale; 2022 Jun; 14(24):8709-8726. PubMed ID: 35673987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
    Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
    ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases.
    Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H
    Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.
    Beldman TJ; Senders ML; Alaarg A; Pérez-Medina C; Tang J; Zhao Y; Fay F; Deichmöller J; Born B; Desclos E; van der Wel NN; Hoebe RA; Kohen F; Kartvelishvily E; Neeman M; Reiner T; Calcagno C; Fayad ZA; de Winther MPJ; Lutgens E; Mulder WJM; Kluza E
    ACS Nano; 2017 Jun; 11(6):5785-5799. PubMed ID: 28463501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles.
    Hossaini Nasr S; Rashidijahanabad Z; Ramadan S; Kauffman N; Parameswaran N; Zinn KR; Qian C; Arora R; Agnew D; Huang X
    Nanoscale; 2020 May; 12(17):9541-9556. PubMed ID: 32314997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE
    Song Y; Huang Z; Liu X; Pang Z; Chen J; Yang H; Zhang N; Cao Z; Liu M; Cao J; Li C; Yang X; Gong H; Qian J; Ge J
    Nanomedicine; 2019 Jan; 15(1):13-24. PubMed ID: 30171903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Cyclodextrin and Hyaluronic Acid-Modified Targeted Nanodelivery System for Atherosclerosis Prevention.
    Yu J; Ma Y; Zhang X; Wang S; Zhou L; Liu X; Li L; Liu L; Song H; Luo Y; Wen S; Li W; Niu X
    ACS Appl Mater Interfaces; 2024 Jul; 16(27):35421-35437. PubMed ID: 38940349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nanotherapy responsive to the inflammatory microenvironment for the dual-targeted treatment of atherosclerosis.
    Li G; Xu F; Yang B; Lu X; Li X; Qi Y; Teng L; Li Y; Sun F; Liu W
    Nanomedicine; 2022 Jul; 43():102557. PubMed ID: 35390526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation.
    Luo X; Zhang M; Dai W; Xiao X; Li X; Zhu Y; Shi X; Li Z
    J Nanobiotechnology; 2024 Jul; 22(1):440. PubMed ID: 39061065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid nanoparticles for active targeting atherosclerosis.
    Lee GY; Kim JH; Choi KY; Yoon HY; Kim K; Kwon IC; Choi K; Lee BH; Park JH; Kim IS
    Biomaterials; 2015; 53():341-8. PubMed ID: 25890732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cluster of Differentiation-44-Targeting Prussian Blue Nanoparticles Onloaded with Colchicine for Atherosclerotic Plaque Regression in a Mice Model.
    Zhu Y; Fang Y; Wang Y; Han D; Liu J; Tian L; Xu M; Wang Y; Cao F
    ACS Biomater Sci Eng; 2024 Mar; 10(3):1530-1543. PubMed ID: 38372216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice.
    Dou Y; Guo J; Chen Y; Han S; Xu X; Shi Q; Jia Y; Liu Y; Deng Y; Wang R; Li X; Zhang J
    J Control Release; 2016 Aug; 235():48-62. PubMed ID: 27235978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation.
    Boada C; Zinger A; Tsao C; Zhao P; Martinez JO; Hartman K; Naoi T; Sukhoveshin R; Sushnitha M; Molinaro R; Trachtenberg B; Cooke JP; Tasciotti E
    Circ Res; 2020 Jan; 126(1):25-37. PubMed ID: 31647755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytosis of polymeric nanoparticles aided activation of macrophages to increase atherosclerotic plaques in ApoE
    Yin T; Li Y; Ren Y; Fuad ARM; Hu F; Du R; Wang Y; Wang G; Wang Y
    J Nanobiotechnology; 2021 Apr; 19(1):121. PubMed ID: 33910571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species-responsive nano-platform with dual-targeting and fluorescent lipid-specific imaging capabilities for the management of atherosclerotic plaques.
    He Z; Chen Q; Duan X; Zhong Y; Zhu L; Mou N; Yang X; Cao Y; Han Z; He H; Wu S; Wang G; Qin X; Qu K; Zhang K; Liu J; Wu W
    Acta Biomater; 2024 Jun; 181():375-390. PubMed ID: 38734284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation.
    Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y
    EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.
    Manea SA; Vlad ML; Fenyo IM; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
    Redox Biol; 2020 Jan; 28():101338. PubMed ID: 31634818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.
    Luehmann HP; Detering L; Fors BP; Pressly ED; Woodard PK; Randolph GJ; Gropler RJ; Hawker CJ; Liu Y
    J Nucl Med; 2016 Jul; 57(7):1124-9. PubMed ID: 26795285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.